These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4459190)

  • 41. Prepackaging would prevent contamination.
    Eisenberg NH
    J Am Pharm Assoc (Wash); 2000; 40(5):580. PubMed ID: 11029837
    [No Abstract]   [Full Text] [Related]  

  • 42. [Immunochemical analysis of the process of influenza virus purification by means of gel filtration and ultrafiltration].
    Polianskaia NIu; Zhebrun AB
    Tr Inst Im Pastera; 1982; 58():64-9. PubMed ID: 7187556
    [No Abstract]   [Full Text] [Related]  

  • 43. Re: the fourteen-day sterility test: how we got there.
    Olson WP
    PDA J Pharm Sci Technol; 1996; 50(4):198. PubMed ID: 8810830
    [No Abstract]   [Full Text] [Related]  

  • 44. [Possibility of sterilizing eyedrops by a bacterial filtration method].
    Danilenko AA; Sokolova IP; Sipinskaia OF; Kurilenko AV
    Farmatsiia; 1978; 27(5):50-2. PubMed ID: 700186
    [No Abstract]   [Full Text] [Related]  

  • 45. Study on the purification of influenza virus vaccine. Filtration of formalin-inactivated influenza virus with Sepharose 6B.
    Tomita S; Asahara T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):185-96. PubMed ID: 5155555
    [No Abstract]   [Full Text] [Related]  

  • 46. [The preservation of pharmaceutical preparations from microbial contamination].
    Bean HS
    Ann Pharm Fr; 1967 Apr; 25(4):265-70. PubMed ID: 5616103
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
    Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
    J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Settling and impaction of particles into containers in manufacturing pharmacies.
    Whyte W
    J Parenter Sci Technol; 1981; 35(5):255-61. PubMed ID: 7299604
    [No Abstract]   [Full Text] [Related]  

  • 50. [Viral vaccines--current status and developmental trends].
    Starke G
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):495-503. PubMed ID: 4940028
    [No Abstract]   [Full Text] [Related]  

  • 51. Parameters governing steam sterilization of deadlegs.
    Young JH; Ferko BL; Gaber RP
    J Pharm Sci Technol; 1994; 48(3):140-7. PubMed ID: 8069515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization].
    Pawlaczyk J; Nowacka D
    Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on microbial contamination of infusion fluids arising from drug additions and administration.
    Ernerot L; Thorén S; Sandell E
    Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099
    [No Abstract]   [Full Text] [Related]  

  • 54. Disinfection of containers and stoppers prior to sterility testing veterinary biological products.
    Christianson GG; Koski TA
    J Biol Stand; 1976 Apr; 4(2):155-61. PubMed ID: 932046
    [No Abstract]   [Full Text] [Related]  

  • 55. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM; Holmes TH; Stamatis S; Tu W; He XS; Bouvier N; Kemble G; Greenberg HB; Lewis DB; Arvin AM; Dekker CL
    Pediatr Infect Dis J; 2007 Feb; 26(2):107-15. PubMed ID: 17259871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Theoretical qualitative aspects of biological indicators of sterilization].
    Bella G
    Boll Chim Farm; 1985 Jul; 124(7):306-20. PubMed ID: 4074521
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 58. The contamination of ampoules in connection with opening.
    Ernerot L; Dahlinder LE
    Acta Pharm Suec; 1969 Jun; 6(3):401-6. PubMed ID: 5824855
    [No Abstract]   [Full Text] [Related]  

  • 59. Issues of biological assays for viral vaccines.
    Lee CK
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Automated particulate detection for ampuls with use of the probabilistic particulate detection model.
    Knapp JZ; Kushner HK; Abramson LR
    J Parenter Sci Technol; 1981; 35(1):21-35. PubMed ID: 7229827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.